Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study (Q33280166)

25 July 2017

Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study (English)

1 reference

25 July 2017

1 reference

1 reference

Maurizio Fadda

2

0 references

Anna Sapino

object named as

Anna Sapino

series ordinal

4

0 references

author name string

Giovanni C Actis

series ordinal

1

1 reference

PubMed ID

17389040

25 July 2017

Ezio David

series ordinal

3

1 reference

25 July 2017

27 March 2007

1 reference

25 July 2017

1 reference

25 July 2017

7

1 reference

25 July 2017

13

1 reference

Creative Commons Attribution 2.0 Generic

25 July 2017

start time

27 March 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-230x-7-13

0 references

cites work

Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852110

Infliximab for induction and maintenance therapy for ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852110

Review article: how and when to use ciclosporin in ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852110

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852110

Intravenous cyclosporin in ulcerative colitis: a five-year experience

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852110

Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852110

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852110

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852110

Further experience in the treatment of severe attacks of ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852110

Ciclosporin use in acute ulcerative colitis: a long-term experience

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-13

Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-13

Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-13

Childhood hepatocellular adenoma in familial adenomatous polyposis: mutations in adenomatous polyposis coli gene and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-13

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-13

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-13

Infliximab for hospitalized patients with severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-13

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-13

Tailoring cyclosporine according to kinetic profiles: does it allow a low-dose therapeutic schedule?

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17389040

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Preliminary report: cyclosporin in treatment of severe active ulcerative colitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17389040

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-230X-7-13

1 reference

PubMed ID

17389040

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference

PubMed ID

17389040